Description

BSE announces listing of 21,12,994 new equity shares of Trident Texofab Limited from July 28, 2025, issued through warrant conversion on preferential basis.

Summary

BSE has announced the listing of 21,12,994 new equity shares of Trident Texofab Limited (Scrip Code: 540726) effective from Monday, July 28, 2025. These shares were issued at a premium of Rs. 60/- per share (issue price Rs. 70/-) to non-promoters on a preferential basis through conversion of warrants. The new shares rank pari-passu with existing equity shares and are subject to lock-in until January 28, 2026.

Key Points

  • 21,12,994 new equity shares of Rs. 10/- each to be listed
  • Issue price: Rs. 70/- per share (Rs. 10/- face value + Rs. 60/- premium)
  • Issued to non-promoters on preferential basis through warrant conversion
  • Trading commences from July 28, 2025
  • ISIN: INE071Y01013
  • Distinguished numbers: 11854100 to 13967093
  • Shares rank pari-passu with existing equity shares

Regulatory Changes

No regulatory changes announced. This is a routine listing notification for new securities.

Compliance Requirements

Trading members are informed of the new securities listing and are required to update their systems to accommodate trading in the additional shares from the effective date.

Important Dates

  • Allotment Dates: March 17, 2025 (17,04,661 shares) and May 12, 2025 (4,08,333 shares)
  • Trading Commencement: July 28, 2025
  • Lock-in Period Ends: January 28, 2026

Impact Assessment

This is a routine corporate action with minimal market impact. The addition of approximately 21 lakh shares through warrant conversion represents dilution for existing shareholders but follows standard regulatory procedures. The lock-in period until January 2026 ensures these shares cannot be immediately traded by allottees, providing stability to the stock price. The preferential allotment to non-promoters indicates capital raising activity by the company.

Impact Justification

Routine listing of new shares through warrant conversion with minimal market impact due to small number of shares relative to total equity base